R. Shandil

发表

Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene

S. Cole, S. Waddell, P. Butcher, 2012 .

Isoniazid Pharmacokinetics-Pharmacodynamics in an Aerosol Infection Model of Tuberculosis

E. Kantharaj, V. Nandi, S. Bharath, 2004, Antimicrobial Agents and Chemotherapy.

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.

Christopher B. Cooper, Amit K. Gupta, D. Murray, 2017, Journal of medicinal chemistry.

High-Throughput Screen for Inhibitors of Transglycosylase and/or Transpeptidase Activities of Escherichia coli Penicillin Binding Protein 1b

R. Shandil, P. Kaur, S. Ravishankar, 2004, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics-Pharmacodynamics of Rifampin in an Aerosol Infection Model of Tuberculosis

E. Kantharaj, V. Nandi, S. Gaonkar, 2003, Antimicrobial Agents and Chemotherapy.

Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway

Amit K. Gupta, G. Balakrishnan, A. Narayan, 2016 .

Vaginosis: Advances in new therapeutic development and microbiome restoration.

U. Krishnan, S. Narayanan, R. Shandil, 2022, Microbial pathogenesis.

Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis

Amit Singh, A. Seshasayee, R. Rajmani, 2019, Science Translational Medicine.

Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: Evaluation of In Vitro and Pharmacodynamic Indices That Best Predict In Vivo Efficacy

V. Nandi, S. Bharath, S. Gaonkar, 2006, Antimicrobial Agents and Chemotherapy.

High-Throughput Screen for Inhibitors of Transglycosylase and/or Transpeptidase Activities of Escherichia coli Penicillin Binding Protein 1b

R. Shandil, P. Kaur, S. Ravishankar, 2004, Antimicrobial Agents and Chemotherapy.

Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases

S. Narayanan, R. Shandil, Saumya Dhup, 2022, Stem cells international.

Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis

R. Guleria, U. Singh, A. Mohan, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A multi-targeting pre-clinical candidate against drug-resistant tuberculosis.

N. Loman, G. Besra, S. Narayanan, 2021, Tuberculosis.

Plasmodium vivax liver stage assay platforms using Indian clinical isolates

Brice Campo, Kouichi Hasegawa, Varadharajan Sundaramurthy, 2020, Malaria Journal.

Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis

Stewart T. Cole, Claudia Sala, Vadim Makarov, 2009, Science.

Two Decades of TB Drug Discovery Efforts—What Have We Learned?

R. Shandil, T. Balganesh, Balachandra S Bandodkar, 2020, Applied Sciences.

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

J. Mckinney, L. Chiarelli, N. Dhar, 2014, Journal of medicinal chemistry.

Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.

Vijay T. Ahuja, A. Srivastava, A. Narayan, 2013, Journal of medicinal chemistry.

1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis

Christopher B. Cooper, S. Narayanan, C. Cooper, 2014, Antimicrobial Agents and Chemotherapy.

Lead optimization of 1,4-azaindoles as antimycobacterial agents.

Christopher B. Cooper, S. Butler, A. Srivastava, 2014, Journal of medicinal chemistry.

Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

Christopher B. Cooper, S. Butler, A. Narayan, 2019, ACS medicinal chemistry letters.

In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis

Vijay T. Ahuja, V. Ramachandran, R. Shandil, 2013, Antimicrobial Agents and Chemotherapy.

Aerosol Infection Model of Tuberculosis in Wistar Rats

S. Bharath, S. Gaonkar, R. Shandil, 2010, International journal of microbiology.

Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense

Sudha Ramaiah, A. Anbarasu, S. Narayanan, 2016, PloS one.

Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria

S. Narayanan, R. Shandil, S. Wittlin, 2020, Malaria Journal.

In Silico-Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis Treatment

Anima Anandkumar, S. Narayanan, V. Ramachandran, 2015, Antimicrobial Agents and Chemotherapy.

A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters

S. Mueller, R. Mehla, S. Narayanan, 2023, Vaccines.

Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria

S. Narayanan, R. Shandil, S. Wittlin, 2020, Malaria journal.

Pharmacokinetic and Pharmacodynamic Evaluation of AZD5847 in a Mouse Model of Tuberculosis

S. Butler, S. Bharath, S. Gaonkar, 2014, Antimicrobial Agents and Chemotherapy.

Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis

Anirban Ghosh, K. Mukherjee, V. Subbulakshmi, 2013, Antimicrobial Agents and Chemotherapy.

Study of the Interaction between Bacteriophage T4 asiA and Escherichia coli ς70, Using the Yeast Two-Hybrid System: Neutralization of asiA Toxicity to E. coli Cells by Coexpression of a Truncated ς70 Fragment

R. Shandil, T. Balganesh, U. Sharma, 1999 .

Whole cell screen based identification of spiropiperidines with potent antitubercular properties.

Vasanthi Ramachandran, Riccardo Manganelli, S. Cole, 2015, Bioorganic & medicinal chemistry letters.

Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice.

V. Subbulakshmi, S. Bharath, S. Gaonkar, 2009, Microbiology.

Development and validation of LC/MS/MS method for Triciribine and its monophosphate metabolite in plasma and RBC: Application to mice pharmacokinetic studies.

S. Narayanan, R. Shandil, N. Surendran, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Recombinant Human ACE2-Fc : A promising therapy for SARS-CoV2 infection

K. Biswas, S. Narayanan, G. R. Rudramurthy, 2022, bioRxiv.

Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis

S. Cole, S. Waddell, P. Butcher, 2009, Science.

Pharmacokinetics and dose response of anti-TB drugs in rat infection model of tuberculosis.

R. Shandil, J. Reddy, B. Pavithra, 2014, Tuberculosis.

Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo

Saumitra Das, R. Narayan, M. Sharma, 2023, Cell Reports Medicine.

In vitro and in vivo efficacy of beta-lactams against replicating and slowly 1 growing/non replicating M. tuberculosis 2

Vijay T. Ahuja, V. Ramachandran, R. Shandil, 2013 .

In Silico-Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis Treatment

Anima Anandkumar, V. Ramachandran, R. Shandil, 2015, Antimicrobial Agents and Chemotherapy.